TY  - JOUR
AU  - van Werkhoven, Cornelis H
AU  - Ducher, Annie
AU  - Berkell, Matilda
AU  - Mysara, Mohamed
AU  - Lammens, Christine
AU  - Torre-Cisneros, Julian
AU  - Rodriguez-Baño, Jesus
AU  - Herghea, Delia
AU  - Cornely, Oliver A
AU  - Biehl, Lena M
AU  - Bernard, Louis
AU  - Dominguez-Luzon, M Angeles
AU  - Maraki, Sofia
AU  - Barraud, Olivier
AU  - Nica, Maria
AU  - Jazmati, Nathalie
AU  - Sablier-Gallis, Frederique
AU  - de Gunzburg, Jean
AU  - Mentre, France
AU  - Malhotra-Kumar, Surbhi
AU  - Bonten, Marc J M
AU  - Vehreschild, Maria J G T
PY  - 2021
DO  - 10.1038/s41467-021-22269-y
UR  - http://hdl.handle.net/10668/17578
T2  - Nature communications
AB  - Trial enrichment using gut microbiota derived biomarkers by high-risk individuals can improve the feasibility of randomized controlled trials for prevention of Clostridioides difficile infection (CDI). Here, we report in a prospective observational...
LA  - en
PB  - Nature Publishing Group
KW  - Aged
KW  - Anti-bacterial agents
KW  - Biomarkers
KW  - Carbapenems
KW  - Cephalosporins
KW  - Clostridioides difficile
KW  - Clostridium Infections
KW  - Drug therapy, combination
KW  - Female
KW  - Fluoroquinolones
KW  - Follow-up studies
KW  - Gastrointestinal microbiome
KW  - Hospitalization
KW  - Humans
KW  - Incidence
KW  - Male
KW  - Middle aged
KW  - Penicillins
KW  - Prospective studies
TI  - Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics.
TY  - Research article
VL  - 12
ER  -